NCT02123849View on ClinicalTrials.gov

Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

February 28, 2018

Conditions
Lung CarcinomaTobacco Use Disorder
Interventions
DRUG

Aspirin

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Placebo

Given PO

Trial Locations (2)

85724

The University of Arizona Medical Center-University Campus, Tucson

02118

Boston University School of Medicine, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT02123849 - Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers | Biotech Hunter | Biotech Hunter